Mediolanum farmaceutici S.p.A Company Profile

23:12 EDT 18th March 2018 | BioPortfolio



Via S.G. Cottolengo, 15


Phone: 39 0289132.1
Fax: 39 0289132.295

News Articles [20 Associated News Articles listed on BioPortfolio]

Mediolanum licences Apeptico’s TNF peptide Solnatide

Control Capability Drives Pump Selection at Fidia Farmaceutici

A leading European manufacturer of health products is benefiting from the control capabilities of peristaltic pumps from Watson-Marlow Fluid Technology Group (WMFTG). The pumps are being used for the...

Protalix BioTherapeutics Enters into an Exclusive Ex-US Partnership with Chiesi Farmaceutici for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

Protalix grants Chiesi Ex-US rights to PRX-102, a chemically modified version of the recombinant protein alpha-Galactosidase-A protein Protalix to receive $25 million upfront, an additional up to...

Pending EC decision: CHF 5993 Chiesi Farmaceutici S.p.A., beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium, Opinion date: 22-Feb-2018

Kamada, Chiesi Farmaceutici Terminate Inhaled Alpha-1 Antitrypsin Therapy Deal

Kamada now maintains full, worldwide commercial rights to its inhaled AAT.

Excelencia farmacéutica italiana en I+D durante el 33rd Congress of the European Association ...

     (Logo: Fidia Farmaceutici anunció hoy los resultados positivos de un ensayo en fase II en el que se evalúa la efica...

Kamada and Chiesi Farmaceutici S.p.A. Mutually Agree to Terminate European Distribution Agreement for Inhaled Alpha-1 Antitrypsin Therapy for Treatment of Alpha-1 Antitrypsin Deficiency

Following Kamada’s Recent Withdrawal of European Marketing Authorization Application, Distribution Agreement Not Currently Warranted REHOVOT, Israel, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Kamada ...

Pharmazeutische F&E-Spitzenleistung aus Italien beim 33. ...

     (Logo: Fidia Farmaceutici gab heute die positiven Ergebnisse einer Phase-II-Studie bekannt, in der Wirksamkeit und Vertr...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Curosurf [Cornerstone Therapeutics Inc.]

CUROSURF (poractant alfa)Intratracheal Suspension

PubMed Articles [0 Results]


Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Evaluation of the filler performance on the nasolabial folds of Aliaxin® EV with and without lidocaine 0.3%: comparison within subjects (half face method)

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Aim of the study is to evaluate the re-volumizing performance and the duration effect of the product Aliaxin (new trademark) in women aged 40-65 years with midface volume defects due to ag...

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial

The rational of intra-articular viscosupplementation is based on both the biological and mechanical properties of HA, which exerts positive effects on the modulation of the entire joint en...

Companies [5 Associated Companies listed on BioPortfolio]

Mediolanum farmaceutici S.p.A


Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

Dompé Farmaceutici S.p.A.

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular patholog...

Fidia Pharma USA Inc.

Fidia Pharma USA Inc., headquartered in Parsippany, NJ, is a wholly-owned subsidiary of the multinational pharmaceutical company Fidia Farmaceutici SpA. Fidia Pharma USA is focuse...

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's mos...

More Information about "Mediolanum farmaceutici S.p.A" on BioPortfolio

We have published hundreds of Mediolanum farmaceutici S.p.A news stories on BioPortfolio along with dozens of Mediolanum farmaceutici S.p.A Clinical Trials and PubMed Articles about Mediolanum farmaceutici S.p.A for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mediolanum farmaceutici S.p.A Companies in our database. You can also find out about relevant Mediolanum farmaceutici S.p.A Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record